Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates
Abstract Background Current effective breast cancer treatment options have severe side effects, highlighting a need for new therapies. Drug repurposing can accelerate improvements to care, as FDA-approved drugs have known safety and pharmacological profiles. Some drugs for other conditions, such as...
Saved in:
Main Authors: | Panagiotis N. Lalagkas, Rachel D. Melamed |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-11-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40246-024-00688-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates
by: Panagiotis N. Lalagkas, et al.
Published: (2025-01-01) -
Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study
by: Lilly Sophia Brandstetter, et al.
Published: (2025-01-01) -
Genetic and epigenetic alterations in night shift nurses with breast cancer: a narrative review
by: Xia Li, et al.
Published: (2025-01-01) -
Dysmenorrhea: Predisposing Factors, Effects on Activities and Health-seeking Behavior among University Students in Ibadan, Nigeria
by: Ayodeji Adeyemo, et al.
Published: (2024-12-01) -
Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for <i>Trypanosoma cruzi</i> Infection
by: Citlali Vázquez, et al.
Published: (2024-12-01)